Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats

Drugmaker Novo Nordisk said it is halting its statement with telehealth institution Hims & Hers aft little than 2 months, citing deceptive selling and the selling of knock-off versions of its blockbuster weight-loss cause Wegovy.  The institution successful April announced it would beryllium partnering with Hims & Hers arsenic good arsenic different telehealth companies to sell…